Coronary heart disease (CHD) is a leading cause of morbidity and mortality globally. Hypercholesterolemia is one of the major risk factors for CHD. With the increase in aging populations and ...

Treatments approved for PAH may reduce by half the risk of serious complications or death in patients with repaired ...

The AHA’s Better Health for Mothers and Babies Initiative (BHMB) offers tools and resources that hospitals and health systems ...

For decades, the management of coronary artery disease has focused on epicardial obstruction and ischaemia, which is often recognised too late for long-term intervention. This approach limits the ...

This is a major source of cardiovascular morbidity and mortality. We have never been able to treat lipoprotein(a) until now.” ...

Announcing a new article publication for Cardiovascular Innovations and Applications journal. Coronary heart disease (CHD), the most common cause of mortality globally, poses a formidable challenge to ...

PAH treatments show similar efficacy in reducing morbidity/mortality in CHD-PAH and PAH patients, with a 50% risk reduction in CHD-PAH. Improvements in 6-minute walking distance and NT-proBNP ...